Ikramuddin S.Korner J.Lee W.J.Connett J.E.Inabnet W.B.Billington C.J.Thomas A.J.Leslie D.B.Chong K.Jeffery R.W.Ahmed L.Vella A.LEE-MING CHUANGBessler M.Sarr M.G.Swain J.M.Laqua P.Jensen M.D.Bantle J.P.2020-06-012020-06-0120151520-9156https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923116092&doi=10.1089%2fdia.2015.1509&partnerID=40&md5=87bf6e52dc473776ca3a13de6cb59b8fhttps://scholars.lib.ntu.edu.tw/handle/123456789/495610[SDGs]SDG3C peptide; hemoglobin A1c; low density lipoprotein cholesterol; bariatric surgery; body mass; body weight; diabetic patient; glycemic control; human; hyperlipidemia; hypertension; intermethod comparison; lifestyle modification; non insulin dependent diabetes mellitus; Note; nutritional deficiency; peroperative complication; postoperative complication; priority journal; randomized controlled trial (topic); Roux Y anastomosis; stomach bypass; surgeon; systolic blood pressure; Taiwan; teaching hospital; United States; weight reductionBariatric Surgery and DiabetesNote10.1089/dia.2015.15092-s2.0-84923116092